{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-062639","form_type":"8-K","ticker":"CLRB","cik":"0001279704","company_name":"Cellectar Biosciences, Inc.","filed_at":"2025-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.824450+00:00","generated_at":"2026-05-18T19:04:53.683005+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cellectar Biosciences completes 1-for-30 reverse stock split effective June 24, 2025","bullets":["Reverse split ratio set at 1-for-30 for common stock, par value $0.00001.","Amendment to Second Amended and Restated Certificate of Incorporation filed.","Fractional shares not issued; aggregate fractions sold by transfer agent and net proceeds distributed pro rata."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-062639","json":"https://secwatch.observer/filing/0001104659-25-062639.json","markdown":"https://secwatch.observer/filing/0001104659-25-062639.md","text":"https://secwatch.observer/filing/0001104659-25-062639.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925062639/0001104659-25-062639-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925062639/tm2519011d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T19:04:53.683005+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"34dcf5b74c21c6c45c5bc12b62c1fbd8cbcbce9b","claim":"Cellectar Biosciences, Inc.: Effected a one-for-thirty reverse stock split by amending the Second Amended and Restated Certificate of Incorporation (effective 2025-06-24).","evidence_excerpt":"On June 24, 2025, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), effected a one-for-thirty reverse stock split of the Company’s common stock, par value $0.00001 (the “Reverse Split”) by amending its Second Amended and Restated Certificate of Incorporation (the “Amendment”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925062639/0001104659-25-062639-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-24"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}